Johnson & Johnson faces a wave of lawsuits from patients who say they were injured when all-metal implants sold by...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
JOHNSON & JOHNSON
Johnson & Johnson is a global pharmaceutical, medical devices and consumer packaged goods manufacturer. Founded in 1886, J&J now includes about 250 subsidiaries in more than 57 countries. A household name in the U.S., the company’s products are sold in more than 175 countries. The topic covers Johnson & Johnson the company, its products and market updates.
Johnson & Johnson is part of Business Exchange, suggested by
Carlton St Bernard.
This topic contains
1,306 news
and
1,891 blog
items.
Read updated news, blogs, and resources about Johnson & Johnson. Find user-submitted articles and reactions on Johnson & Johnson from
like-minded professionals.
News
Recent news on this topic.
Johnson & Johnson said Alex Gorsky, its chief executive, would succeed William C. Weldon, who will step down after...
Stock pierces through recent trading range, signalling higher targets
The announcement extended the company's program to remove certain ingredients from baby products to include adult...
While comprehensive and accurate information (the kind Research tends to provide) makes a decision appear “well thought...
Many marketers focus primarily on subjects that are within their span of control—such as features, package, and price.
Johnson & Johnson and Gilead Sciences Inc. won U.S. approval of a once-daily HIV treatment that combines multiple...
An agreement in principle was reached on a misdemeanor criminal charge related to the marketing of the antipsychotic...
Extract not available.
Since electronic words are cheap, here I present something I really hated to see go from the paper version.
Extract not available.
/PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE: JNJ) will review growth strategies for its Pharmaceuticals...
Extract not available.
Extract not available.
Discussing which indicators need to change before jumping back into the markets, with Chris Johnson, Johnson Research...
During last week's bond blizzard, Johnson & Johnson (NYSE: JNJ With the low bond yield, income investors...
intent on meeting surging demand for treatments. BeiGene Ltd. hired 20 U.S.-educated scientists from companies...
intent on meeting surging demand for treatments. BeiGene Ltd. hired 20 U.S.-educated scientists from companies...
Oaks, California-based Amgen; Humira, from Abbott Park, Illinois-based Abbott Laboratories; and Remicade, sold by New...
India's JB Chemicals , which has sold several over-the-counter brands in Russia to Johnson & Johnson , will now...
NEW YORK (TheStreet) -- The ex-dividend date for Johnson & Johnson (NYSE:JNJ) is tomorrow, May 26, 2011.
Extract not available.
& Pharmaceuticals Ltd (JBCPL) has decided to sell its over-the-counter (OTC) business in Russia and CIS countries...
its acquisition of Russia's largest OTC drug business, and future growth, with William Weldon, Chairman & CEO,...
Top Sources: Johnson & Johnson
- BusinessWeek
- Financial Times
- TheStreet.com
- New York Times
- Reuters
- Motley Fool
- thedeal.com
- bloomberg.com
- Wall Street Journal Online
- MarketWatch
account